A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
about
A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewMolecular genetics and targeted therapeutics in biliary tract carcinoma.Current therapy and future directions in biliary tract malignancies.A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study.Emerging drugs for biliary cancer.Trial Watch: Chemotherapy with immunogenic cell death inducers.
P2860
Q33423590-7317E774-5002-4DBE-AA32-E08DED5334B1Q36270115-198DACD1-6B40-4828-842C-A211B2CA1142Q36488070-DB899BC8-F599-4233-BDAB-57ABE1708006Q37161293-AE979545-225D-4E14-A2CD-9DC7208B14AEQ37458491-3F3444C6-2D5A-4ECC-80BC-911E4EE32F46Q51327505-2FEAEA77-DE0E-4105-B6D1-D9E2A5C27D51Q55260834-DAC77DA0-1967-4847-97EA-A2F6079B1103
P2860
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A phase I study of sorafenib, ...... consin oncology network study.
@ast
A phase I study of sorafenib, ...... consin oncology network study.
@en
type
label
A phase I study of sorafenib, ...... consin oncology network study.
@ast
A phase I study of sorafenib, ...... consin oncology network study.
@en
prefLabel
A phase I study of sorafenib, ...... consin oncology network study.
@ast
A phase I study of sorafenib, ...... consin oncology network study.
@en
P2093
P2860
P1476
A phase I study of sorafenib, ...... consin oncology network study.
@en
P2093
Anne M Traynor
Daniel L Mulkerin
David Groteluschen
Dustin A Deming
Emily Robinson
Hilary R Hernan
Kurt Oettel
Kyle D Holen
Noelle K LoConte
Sam J Lubner
P2860
P2888
P304
P356
10.1007/S10637-012-9916-5
P577
2012-12-21T00:00:00Z
P6179
1012288268